Hydrogel-Based Formulations for Drug Delivery to the Posterior Segment of the Eye
Annals of Biomedical Science and Engineering · 12.09.2023 · 7 (1) · 038-050
DOI: 10.29328/journal.abse.1001024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Biomedical Science and Engineering, online erschienen am 12.09.2023. Verfasst von AmirHossein Bahmanpour und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hydrogel-based formulations hold significant promise for treating ocular diseases that impact the posterior segment of the eye. These formulations exhibit the ability to surmount ocular barriers and offer sustained drug release, rendering them efficacious drug delivery systems. This article addresses the challenges linked to treating disorders affecting the posterior eye segment and underscores the imperative for less invasive drug delivery methodologies. We further delve into diverse contemporary ocular dosage forms, encompassing gels, nanostructures, and implants, with a specific emphasis on hydrogels. Hydrogels offer several merits, including precise targeting, sustained release, enhanced bioavailability, and non-invasiveness. Moreover, they curtail the risk of adverse effects and foster patient adherence. An enthralling advancement is the amalgamation of hybrid drug delivery systems, integrating nanoparticles, liposomes, dendrimers, and stimuli-activated nano-systems, with hydrogels for posterior eye ailment treatment. These hybrid nano-systems exhibit promise in enhancing drug stability, prolonging drug release, and pinpointing specific tissues within the posterior segment. We also provide an overview of ongoing clinical trials and approved hydrogel-based drug delivery systems, like Retisert and Ozurdex. These systems have demonstrated efficacy in managing chronic non-infectious uveitis, Age-related Macular Degeneration (AMD), and diabetic macular edema. Nevertheless, challenges persist, including optimizing bioavailability, maintaining drug stability, and implementing personalized treatment approaches. The incessant evolution of gel-based drug delivery systems stands to substantially enhance patients’ quality of life and establish new benchmarks in treating posterior eye diseases. The future of ophthalmology brims with excitement, as gel-based drug delivery systems hold the potential to revolutionize ocular therapies, providing effective remedies for an array of vision-related afflictions.
Zitieren
APA
Bahmanpour, A., Mollazadeh-Bajestani, M., Ghaffari, M., Moztarzadeh, F., & Sepahvandi, A. (2023). Hydrogel-Based Formulations for Drug Delivery to the Posterior Segment of the Eye. Annals of Biomedical Science and Engineering, 7(1), 038-050. https://doi.org/10.29328/journal.abse.1001024
Vancouver
Bahmanpour A, Mollazadeh-Bajestani M, Ghaffari M, Moztarzadeh F, Sepahvandi A. Hydrogel-Based Formulations for Drug Delivery to the Posterior Segment of the Eye. Annals of Biomedical Science and Engineering. 2023;7(1):038-050. doi:10.29328/journal.abse.1001024
BibTeX
@article{Bahmanpour2023,
author = {Bahmanpour, AmirHossein and Mollazadeh-Bajestani, Maryam and Ghaffari, Maryam and Moztarzadeh, Fathollah and Sepahvandi, Azadeh},
title = {Hydrogel-Based Formulations for Drug Delivery to the Posterior Segment of the Eye},
journal = {Annals of Biomedical Science and Engineering},
year = {2023},
volume = {7},
number = {1},
pages = {038--050},
doi = {10.29328/journal.abse.1001024}
}
EUVIMED